Status:
COMPLETED
Survey Study on Barrett's Esophagus Screening
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
American College of Gastroenterology
Conditions:
Gastroesophageal Reflux Disease
Barrett's Esophagus
Eligibility:
All Genders
18-99 years
Brief Summary
The goal of this study is to optimize Barrett's Esophagus (BE) screening to reduce the incidence, morbidity, and mortality of Esophageal Adenocarcinoma (EAC).
Detailed Description
The initial step to achieve this goal is to study shortcomings of the current BE screening referral processes in the United States. These shortcomings will be identified through completion of two syne...
Eligibility Criteria
Inclusion
- Patient Eligibility Criteria
- Patients identified by ICD-10 codes for GERD (K21.0 and K21.9) AND
- Have had at least one outpatient clinic visit at a participating site
Exclusion
- Prior diagnosis of BE/EAC
- Non-English speaking
- Provider Eligibility Criteria
- Inclusion Criteria:
- Provider must be a PCP and/or gastroenterologist AND
- Must be at a participating site
Key Trial Info
Start Date :
February 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2025
Estimated Enrollment :
725 Patients enrolled
Trial Details
Trial ID
NCT04408105
Start Date
February 19 2020
End Date
October 1 2025
Last Update
October 22 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Denver Health Medical Center
Aurora, Colorado, United States, 80045
2
University of Colorado Hospital
Aurora, Colorado, United States, 80045
3
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
4
Pennsylvania Hospital
Philadelphia, Pennsylvania, United States, 19104